Shoichi Kuroda

The first total synthesis and structural determination of lagunamycin

Seijiro Hosokawa, Shoichi Kuroda, Keisuke Imamura et al. · Tetrahedron Letters · 2006 · 30 citations

Biochemistry, First Total Synthesis, Pharmacology +2

Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase γ inhibitor for the treatment of inflammatory diseases

Yusuke Oka, Tetsuya Yabuuchi, Takahiro Oi et al. · Bioorganic & Medicinal Chemistry · 2013 · 21 citations · Full text

Inflammation, Molecular Pharmacology, Medicinal Chemistry +12

Discovery of potent, low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor SGL5213 for type 2 diabetes treatment

Shoichi Kuroda, Yohei Kobashi, Takahiro Oi et al. · Bioorganic & Medicinal Chemistry · 2018 · 15 citations · Full text

Inhibitor Sgl5213, Diabetes Management, Biochemistry +8

Discovery of a potent, low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor (TP0438836) for the treatment of type 2 diabetes

Shoichi Kuroda, Yohei Kobashi, Takahiro Oi et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 14 citations · Full text

Diabetes Management, Biochemistry, Medicine +5